SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 196 filers reported holding SAGE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $108,107 | -47.3% | 5,253 | +20.3% | 0.00% | -50.0% |
| Q2 2023 | $205,289 | +17.4% | 4,366 | +4.8% | 0.01% | +14.3% |
| Q1 2023 | $174,889 | -1.6% | 4,168 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $177,807 | +17.0% | 4,168 | +6.7% | 0.01% | 0.0% |
| Q3 2022 | $152,000 | +20.6% | 3,907 | 0.0% | 0.01% | +40.0% |
| Q2 2022 | $126,000 | -77.9% | 3,907 | +10.6% | 0.01% | -81.5% |
| Q1 2018 | $569,000 | +6.2% | 3,534 | +8.6% | 0.03% | +12.5% |
| Q4 2017 | $536,000 | +115.3% | 3,254 | +7.3% | 0.02% | +100.0% |
| Q3 2017 | $249,000 | +2.9% | 3,034 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $242,000 | +34.4% | 3,034 | +19.6% | 0.01% | +33.3% |
| Q1 2017 | $180,000 | – | 2,537 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |